menu
    • menu
    [{"orgOrder":0,"company":"Royal DSM","sponsor":"National Liver Institute, Egypt | Cairo University | High Institute of Public Health, Egypt","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"NETHERLANDS","productType":"Miscellaneous","year":"2014","type":"Inapplicable","leadProduct":"Arachidonic Acid","moa":"Prostaglandin G\/H synthase 1 (COX-1)","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Royal DSM","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Oil","sponsorNew":"Royal DSM \/ National Liver Institute, Egypt | Cairo University | High Institute of Public Health, Egypt","highestDevelopmentStatusID":"1","companyTruncated":"Royal DSM \/ National Liver Institute, Egypt | Cairo University | High Institute of Public Health, Egypt"},{"orgOrder":0,"company":"University of Alberta","sponsor":"Mead Johnson Nutrition","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"CANADA","productType":"Miscellaneous","year":"2014","type":"Inapplicable","leadProduct":"Arachidonic Acid","moa":"Prostaglandin G\/H synthase 1 (COX-1)","graph1":"Undisclosed","graph2":"Phase I","graph3":"University of Alberta","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Alberta \/ Mead Johnson Nutrition","highestDevelopmentStatusID":"6","companyTruncated":"University of Alberta \/ Mead Johnson Nutrition"}]

    Find Clinical Drug Pipeline Developments & Deals for all-cis-eicosa-5,8,11,14-tetraenoic acid

    Menu

    all-cis-eicosa-5,8,11,14-tetraenoic acid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Royal DSM

                            Netherlands arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Royal DSM

                            Netherlands arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Arachidonic Acid

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Undisclosed

                            Sponsor : National Liver Institute, Egypt | Cairo University | High Institute of Public Health, Egypt

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Arachidonic Acid Treatment Against Schistosomiasis Infection in Children

                            Details : Arachidonic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Schistosomiasis.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            May 22, 2014

                            Lead Product(s) : Arachidonic Acid

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : National Liver Institute, Egypt | Cairo University | High Institute of Public Health, Egypt

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            University of Alberta

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            University of Alberta

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Arachidonic Acid

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Sponsor : Mead Johnson Nutrition

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Assessment of Arachidonic Acid Supplementation in Infant Formula on the Immune Response of Infants

                            Details : Arachidonic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            March 20, 2014

                            Lead Product(s) : Arachidonic Acid

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Sponsor : Mead Johnson Nutrition

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth